Libra Therapeutics
Pre-clinicalLibra Therapeutics is advancing new therapeutics to improve lysosomal function with the potential to halt neurodegeneration in amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, Huntington's disease, and more.
Founded
2018
Focus
Small Molecules
About
Libra Therapeutics is advancing new therapeutics to improve lysosomal function with the potential to halt neurodegeneration in amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, Huntington's disease, and more.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile